Tag: Rare Diseases Trend Alert: FDA Approvals – A Year in Review by Magellan Health Insights March 22, 2019 Biosimilars, FDA, FDA Approvals, Magellan, Magellan Health, Magellan Healthcare, New Drug Therapy Approvals, Novel drugs, Orphan Drugs, Rare Diseases What do Employers Need to Know about Escalating Specialty Drug Spend? by Magellan Health Insights May 24, 2017 Autoimmune, Employers, Medical Benefit, Oncology, PBM, Rare Diseases, Specialty Pharmacy Connecting Key Opinion Leaders with Prescribing Doctors – Enhancing Dialogue and Discussion by Magellan Health Insights March 8, 2017 Clinical Connections, Key Opinion Leader, Muscular Dystrophy, Rare Diseases
